Banu Lebe

Prof. Banu Lebe is a seasoned surgical physician and academic leader with a distinguished career in medicine. She earned her professorship from Dokuz Eylül Üniversitesi, Faculty of Medicine, Department of Surgical Medical Sciences in 2011. With a strong foundation in surgical practice and education, she has combined clinical expertise and academic scholarship to advance patient care and train the next generation of surgeons. Since 2025 she has been affiliated with Acıbadem Health Group, where she continues to contribute to high-quality clinical services and multidisciplinary care. Her background reflects a commitment to surgical excellence, medical education, and collaborative healthcare delivery.

Education

• 2011 Dokuz Eylül Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü – Prof. Dr.
• 2005 – 2011 Dokuz Eylul University, Department of Surgical Medical Sciences – Assoc. Prof. Dr.
• 2001 – 2005 Dokuz Eylul University, Department of Surgical Medical Sciences – Assist. Assoc. Prof. Dr.
• 1998 Dokuz Eylul University Faculty of Medicine Medical Pathology
• 1993 Ankara University Faculty of Medicine

Experience

• 2025 Acibadem Health Group

Publications

• Human Herpesvirus 6-Associated Unilateral Panuveitis Mimicking Endogenous Endophthalmitis in a Case with Ulcerative Colitis: Report of a Case and Literature Review
  Ocular Immunology and Inflammation, 2025 (SCI-Expanded) KARTI Ö., AYHAN Z., LEBE B., SAATCİ A. O.
• The Relationship of PRAME Expression with Clinicopathologic Parameters and Immunologic Markers in Melanomas: In Silico Analysis
  Applied Immunohistochemistry and Molecular Morphology, vol.33, sa.2, pp.117-130, 2025 (SCI-Expanded) Cakir Y., LEBE B.
• Diagnostic Performance of Dermoscopy for Distinguishing Early Melanomas and Intermediate Melanocytic Lesions From Low-Grade Dysplastic Nevi
  Journal of Cutaneous Medicine and Surgery, 2025 (SCI-Expanded) AVCI C., Kaşıkçı M., LEBE B., AKARSU S., İLKNUR T.
• Genetic and Epigenetic Changes in Melanoma Progression: A TCGA-based Study
  Applied Immunohistochemistry and Molecular Morphology, vol.33, no.3, pp.170-179, 2025 (SCI-Expanded) ÇAKIR Y., LEBE B., TOPER M., SARIOĞLU S.
• Can we manage the melanocytic lesions with peripheral globules according to the grade of dysplasia?
  The Australasian journal of dermatology, vol.65, sa.4, pp.358-368, 2024 (SCI-Expanded) Avcı C., Akın G. N., Lebe B., Şahin M. T., Fetil E.
• Febrile ulceronecrotic Mucha-Habermann disease during pregnancy: A case report.
  The Australasian journal of dermatology, vol.64, sa.2, pp.245-248, 2023 (SCI-Expanded) Avcı C., Gürbüz Ö., Özbağçıvan Ö., Lebe B.
• Pyoderma gangrenosum and Behcet’s-like disease induced by secukinumab: a paradoxical drug reaction.
  The Journal of dermatological treatment, vol.34, sa.1, pp.2235040, 2023 (SCI-Expanded) Avcı C., Akın G. N., Akarsu S., Lebe B.
• Clinicopathologic characteristics of BRAF V600K mutant malignant melanoma in comparison with V600E mutant cases: a preliminary study
  VIRCHOWS ARCHIV, vol.481, sa.SUPPL 1, 2022 (SCI-Expanded) Bulbul G., Agalar A. A., Yumuk E., Cagaptay S., Ellidokuz H., Lebe B.
• Exacerbation of lupus erythematosus panniculitis after administration of COVID-19 mRNA vaccine
  INDIAN JOURNAL OF DERMATOLOGY, vol.67, sa.6, pp.825-828, 2022 (SCI-Expanded) Avcı C., Şirin N. D., İlknur T., Lebe B., Akarsu S.
• Viral exanthema in a COVID-19 patient
  VIRCHOWS ARCHIV, vol.481, sa.SUPPL 1, 2022 (SCI-Expanded) Yumuk E., Cagaptay S., Bulbul G., Lebe B.